Eli Lilly to Acquire AtaiBeckley for $6.75/Share Cash + CVRs, ~$2.8B Upfront
ATAI has more than doubled off its 52-week low of $2.58.
Summary
Eli Lilly agreed to acquire AtaiBeckley for $6.75 per share in cash plus up to $2.50 per share in CVRs, representing a total upfront equity value of ~$2.8 billion. The deal, which carries a 40% premium, is expected to close in Q3 2026.
Key Events · M&A and Partnerships · ATAI
-
Acquisition by Eli Lilly
Eli Lilly will acquire all outstanding shares for $6.75 per share in cash plus up to $2.50 per share in contingent value rights (CVRs), representing an upfront equity value of ~$2.8 billion and potential additional ~$1.0 billion.
-
Premium to Market
The $6.75 cash offer represents a 40% premium to the 30-day volume-weighted average trading price as of July 15, 2026.
-
CVR Milestones
CVRs pay up to $1.00/share upon Phase 3 initiation of VLS-01, $0.50/share upon U.S. approval and DEA rescheduling of BPL-003, and $1.00/share upon U.S. approval and DEA rescheduling of VLS-01, each subject to specific deadlines.
-
Termination Fee
AtaiBeckley must pay Eli Lilly a $104.3 million termination fee if the deal is terminated under certain circumstances, including accepting a superior proposal.
Analysis · ATAI · Life Sciences
In a thesis-altering move, Eli Lilly will acquire AtaiBeckley for an upfront equity value of approximately $2.8 billion, with an additional $1.0 billion in potential milestone payments via contingent value rights. The $6.75 per share cash offer delivers a 40% premium to the 30-day VWAP, handing shareholders a significant premium while placing the company's pipeline under Lilly's development resources. A $104.3 million termination fee and voting agreements from insiders covering 15% of shares underscore strong commitment. The transaction is expected to close in Q3 2026, subject to shareholder and regulatory approvals.
At the time of this filing, ATAI was trading at $7.20 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2B. The 52-week trading range was $2.58 to $6.75. This filing was assessed with positive market sentiment and an importance score of 10 out of 10.